Analysis of DMI data in diabetes patients

DMI measurements of hepatic glycogen synthesis and de novo lipogenesis in type 2 diabetes patients will be analyzed. Effect-sizes between patients and controls (D2.2) will be calculated. Findings will be correlated to clinical parameters of glucose tolerance and insulin resistance and the degree of liver steatosis as determined by conventional hydrogen MRI and MRS.